Critical Need For a Multi-Modal Approach to Combat Obesity part 2

8728 Views
Was this article interesting to you?

Scientific Sources

How effective is Irvingia for weight loss?

40-participant study (28 Irvingia, 12 placebo): Irvingia lost 5.26% body weight in one month vs 1.32% placebo. Regular diets maintained—no restrictions.

What results from white kidney bean?

8-week study, 27 obese adults: 3.8 pounds weight loss, 1.5 inches abdominal fat, three-fold triglyceride reduction vs placebo.

Does it work better for high-carb consumers?

Yes. Highest carb consumers: 8.7 pounds lost vs 1.7 pounds controls. 3.3 inches belly fat lost in Phaseolus group.

How does Irvingia improve cholesterol?

Irvingia decreases total cholesterol, LDL, triglycerides while increasing HDL. Cardiovascular benefits occur alongside weight loss.

What's the mechanism for white kidney bean?

Phaseolus vulgaris blocks alpha-amylase starch-digesting enzymes in intestine, neutralizing amylase, preventing starch breakdown/absorption, reducing caloric intake.

  • Irvingia gabonensis produces 5.26% body weight loss vs 1.32% placebo (one month)
  • Irvingia decreases total cholesterol, LDL, triglycerides while increasing HDL
  • Irvingia reduces adipogenesis by inhibiting glycerol-3-phosphate dehydrogenase enzyme
  • White kidney bean (8 weeks) produces 3.8 pounds loss and 1.5 inches abdominal fat reduction
  • Phaseolus vulgaris achieves three-fold triglyceride reduction vs placebo
  • White kidney bean in high-carb consumers produces 8.7 pounds vs 1.7 pounds control, 3.3 inches belly fat
  • Phaseolus blocks alpha-amylase preventing starch digestion and carbohydrate absorption
  • Irvingia modulates PPAR gamma, leptin, adiponectin reducing fat deposition

Multi-Modal Obesity Protocol Part 2

Step 1: Assessment

Measure weight, waist, lipids (cholesterol, LDL, HDL, triglycerides), glucose. Document carb intake patterns. Identify high-carb consumers.

Step 2: Irvingia Implementation

Follow 40-participant protocol. Maintain regular diets. Target 5-6% weight loss first month. Monitor lipid improvements: decreased cholesterol, LDL, triglycerides, increased HDL.

Step 3: White Kidney Bean Protocol

General obesity: 8-week protocol (n=27). Expect 3.8 lbs, 1.5 inches abdominal fat, three-fold triglyceride reduction. High-carb consumers: 8.7 lbs vs 1.7 lbs control. Take before carb-rich meals.

Step 4: Mechanism Optimization

Irvingia inhibits glycerol-3-phosphate dehydrogenase (prevents glucose→triglyceride conversion). White kidney bean blocks intestinal alpha-amylase (neutralizes starch digestion).

Step 5: Part 1 Integration

Combine Part 2 (Irvingia + white kidney bean) with Part 1 green tea for comprehensive multi-modal approach: metabolic rate, fat cell biology, carb absorption.

Step 6: Monitoring

30 days: Irvingia effects (5.26% loss target), lipids. 60-90 days: Cumulative effects, 1.5-3.3 inches abdominal reduction, triglycerides. Adjust for carb patterns.

  • Obese seeking weight loss without major diet restructuring (ICD-10: E66.9 - Obesity)
  • Dyslipidemia requiring combined weight/cholesterol management (ICD-10: E78.5 - Hyperlipidemia)
  • High-carb consumers benefiting from absorption blocking (ICD-10: E66.01 - Morbid obesity)
  • Elevated triglycerides (ICD-10: E78.1 - Pure hyperglyceridemia)
  • Abdominal obesity (1.5-3.3 inches reduction) (ICD-10: E66.8 - Other obesity)
  • Multi-modal intervention candidates (ICD-10: E66.3 - Overweight)
  • Impaired glucose metabolism (ICD-10: R73.09 - Prediabetes)
  • Severe malnutrition (BMI <18.5) - carb blockers reduce absorption
  • Inflammatory bowel disease - undigested carbs worsen symptoms
  • Allergies to mango family (Irvingia) or legumes (kidney bean)
  • Pregnancy/breastfeeding - limited safety data
  • Diabetes medications without monitoring - hypoglycemia risk
  • Severe gastroparesis - delayed digestion complications
  • Liver disease - caution with hepatically metabolized supplements

Irvingia Gabonensis Clinical Study (n=40): Randomized study with 28 receiving Irvingia supplement, 12 placebo, one month duration. All subjects maintained regular diets without additional restrictions. Irvingia group: 5.26% body weight loss vs 1.32% placebo. Supplemented patients experienced decreases in total cholesterol, LDL cholesterol, and triglycerides, with increases in beneficial HDL cholesterol.

Citation: Lipids Health Dis. 2005 May 25;4:12.

White Kidney Bean Extract (n=27): Eight-week study of obese adults taking Phaseolus vulgaris extract to neutralize alpha-amylase enzyme. Results: 3.8 pounds weight loss, 1.5 inches abdominal fat reduction. Participants achieved three-fold reduction in triglyceride levels compared with placebo recipients. Study conducted by researchers at UCLA Integrative Medicine Program.

Citation: Altern Med Rev. 2004 Mar;9(1):63-9.

High-Carbohydrate Consumer Study: Second clinical investigation revealed subjects consuming highest dietary starch levels with Phaseolus vulgaris supplementation lost 8.7 pounds compared to only 1.7 pounds in control group. Even more impressive: 3.3 inches of belly fat lost in high-carbohydrate Phaseolus group. Validates carbohydrate-blocking mechanism and demonstrates particular efficacy in populations with significant starch consumption.

Citation: Altern Ther Health Med. 2007 Jul;13(4):32-7.